20 completed, 9 terminated, 6 unknown, 5 withdrawn. 44 Phase 2, 7 Phase 3, 5 Phase 1.
Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Management of Iron Deficiency Anemia in Hemodialysis Patients Lactoferrin, IV iron sucrose - Iron Deficiency Anemia (IDA), ESRD (End Stage Renal Disease) | Phase 2 | Active not recruiting | Beni-Suef University | 108 | 2025-11-02 | 2026-10-30 |
| Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma Iron dextran 1000 mg IV - Anemia, Iron Deficiency, Melanoma | Phase 2 | Withdrawn | Indiana University | 2025-05-01 | 2025-07-09 | |
| A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia). KER-047 - Iron Deficiency Anemia | Phase 2 | Withdrawn | Keros Therapeutics, Inc. | 2023-11-30 | 2023-11-24 | |
| Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill, Intensity-modulated radiotherapy - Nasopharyngeal Carcinoma, Iron-deficiency | Phase 2 | Unknown | Sun Yat-sen University | 120 | 2023-05-05 | 2023-06-22 |
| Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age Mineral-enriched powder, Placebo powder - Iron Deficiency, Iron Deficiency Anaemia | Phase 2 | Completed | Carleton University | 150 | 2023-04-27 | 2026-04-27 |
| Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury Iron dextran, Placebo - Anemia, Iron Deficiency, Acute Kidney Injury | Phase 2 | Completed | Hospital Civil de Guadalajara | 120 | 2023-01-06 | 2024-10-01 |
| Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants Darbepoetin Alfa, Low Molecular Weight Iron Dextran, Ferumoxytol injection - Prematurity, Iron-deficiency | Phase 2 | Recruiting | University of Washington | 120 | 2022-11-27 | 2026-05-26 |
| Oral Iron Supplementation for Patients With Chronic Kidney Disease Ferrous sulfate 3 days week, Ferrous sulfate daily, Ferrous sulfate higher concentration - Chronic Renal Disease, Iron-Deficiency Anemia | Phase 2 | Active not recruiting | Universidade Federal Fluminense | 6 | 2022-08-01 | 2025-04-03 |
| Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia Ferric carboxymaltose - Iron Deficiency, Anaemia | Phase 2 | Withdrawn | American Regent, Inc. | 2022-07-21 | 2023-01-06 | |
| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) Treosulfan, Fludarabine Phosphate, Tacrolimus - Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia | Phase 2 | Completed | Fred Hutchinson Cancer Center | 40 | 2022-04-19 | 2026-03-09 |
| Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer Iron(III)isomaltoside, Placebo - Iron-deficiency, Colorectal Cancer | Phase 2 | Not yet recruiting | Zealand University Hospital | 134 | 2022-03-01 | 2022-03-03 |
| Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy Triferic AVNU, Placebo - Iron Deficiency Anemia | Phase 2 | Unknown | Rockwell Medical Technologies, Inc. | 75 | 2021-11-30 | 2021-11-08 |
| Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) Ferric Derisomaltose 1000 Mg in 100 mL INTRAVENOUS SOLUTION [Monoferric], Placebo - Iron-deficiency, Heart Failure With Preserved Ejection Fraction | Phase 2 / Phase 3 | Completed | Massachusetts General Hospital | 65 | 2021-11-26 | 2026-09-04 |
| Iron Sucrose in Patients With Iron Deficiency and POTS Sucrose, Placebo, Tilt Table Test - Iron-deficiency, Postural Orthostatic Tachycardia Syndrome | Phase 2 | Withdrawn | Mayo Clinic | 2021-04-01 | 2023-06-13 | |
| Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis Intravenous iron isomaltoside, Placebo - Severe Aortic Stenosis, Iron-deficiency | Phase 2 | Completed | Oslo University Hospital | 149 | 2020-01-13 | 2026-04-15 |
| Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients Iron Sucrose - Epithelial Ovarian Cancer, Anemia | Phase 1 / Phase 2 | Terminated | University of Wisconsin, Madison | 9 | 2019-07-29 | 2023-01-05 |
| Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia Iron sucrose, Epoetin Alfa, Placebo - Anemia, Iron Deficiency, Anemia of Chronic Disease | Phase 2 | Terminated | Unity Health Toronto | 4 | 2019-07-01 | 2021-06-18 |
| Probing the Synergistic Effect of Pre-Biotics & Iron Fortificants in Anemic Subjects Prebiotic + Iron Forificant - Iron-deficiency | Phase 1 / Phase 2 | Completed | University of Veterinary and Animal Sciences, Lahore - Pakistan | 75 | 2019-04-06 | 2019-08-22 |
| Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) Ferrous succinate - Vascular Cognitive Impairment, Dementia, Vascular | Phase 2 | Unknown | Beijing Tiantan Hospital | 1006 | 2019-04-01 | 2020-07-13 |
| A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia IOP Injection / MPB-1514 - Iron Deficiency Anemia | Phase 2 | Terminated | MegaPro Biomedical Co. Ltd. | 49 | 2018-11-29 | 2021-10-28 |
Showing 20 of 44. Sign in to see all of them.
Anemia, Iron-Deficiency (43) · Anemia (11) · Iron Deficiencies (10) · Renal Insufficiency, Chronic (4) · Colorectal Neoplasms (2) · Acute Kidney Injury (1) · Anemia, Diamond-Blackfan (1) · Aortic Valve Stenosis (1) · Bone Marrow Failure Disorders (1) · Carcinoma, Ovarian Epithelial (1) · Cardiovascular Diseases (1) · Cerebral Infarction (1) · Congenital amegakaryocytic thrombocytopenia (1) · Dementia (1)
Hematologic Diseases (44) · Hemic and Lymphatic Diseases (44) · Metabolic Diseases (44) · Nutritional and Metabolic Diseases (44) · Iron Metabolism Disorders (43) · Anemia (33) · Iron Deficiencies (33) · Female Urogenital Diseases and Pregnancy Complications (8) · Urogenital Diseases (8) · Digestive System Diseases (6) · Female Urogenital Diseases (6) · Neoplasms (6) · Pathological Conditions, Signs and Symptoms (6) · Male Urogenital Diseases (5)
Iron-Dextran Complex (10) · ferric carboxymaltose (9) · Ferric Oxide, Saccharated (7) · ferrous sulfate (7) · Lactoferrin (4) · Ferrosoferric Oxide (3) · Iron (3) · Sodium Chloride (3) · ferryl iron (2) · Antilymphocyte Serum (1) · Bone Marrow Transplantation (1) · Darbepoetin alfa (1) · Epoetin Alfa (1) · Erythropoietin (1) · Methotrexate (1)
American Regent, Inc. (4) · Mayo Clinic (2) · AMAG Pharmaceuticals, Inc. (1) · Ain Shams University (1) · Auerbach Hematology Oncology Associates P C (1) · Beijing Tiantan Hospital (1) · Beni-Suef University (1) · Carleton University (1) · Fred Hutchinson Cancer Center (1) · Hospital Civil de Guadalajara (1) · Indiana University (1) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · Keros Therapeutics, Inc. (1) · Keryx Biopharmaceuticals (1) · M.D. Anderson Cancer Center (1)
United States (17) · Canada (4) · Egypt (4) · Poland (4) · China (3) · Brazil (2) · Germany (2) · India (2) · Mexico (2) · Norway (2) · Russia (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1)
Mark Falone, MD (2) · Steven Fishbane, MD (2) · Aijun AJ Sun, MD (1) · Bambang B Siswanto, Professor (1) · Bjorn Backe, MD PhD (1) · Christoph Gasche, MD (1) · David Kearney, MD (1) · Dr. Waqas Ahmad, PhD (1) · Gary Hoel, RPh, PhD (1) · Geoffrey Block, MD (1) · Ghada Mohamed, MBBCh (1) · Glenn Chertow, MD (1) · Greg Lewis, MD (1) · Gregory MT Hare, MD PhD (1)
PMID 18191732, PMID 19920054, PMID 23505057, PMID 24458078, PMID 25468387, PMID 25639592, PMID 26028263, PMID 28029503, PMID 28487769, PMID 34241801, PMID 35579454, PMID 36578916, PMID 36691165, PMID 37208431, PMID 38789134, PMID 40576086, PMID 41430711, PMID 41591819
2008 (1), 2009 (1), 2019 (1), R01HD107003 (1), R01HL151841 (1), U10HL069294 (1)